Corporate Profile
We create people's happiness
and future through our work.
As the drug price revision and patent cliff progress, the pharmaceutical industry is facing a major turning point.
In the development of new drugs that are said to take 10 years, it is necessary to further speed up, develop and streamline management.
Since its founding in 1950, Fukuzyu Pharmaceutical has been manufacturing APIs and intermediates necessary for the development stage, with a focus on multi-item, small-lot production. We are working to improve our technical capabilities to meet these needs and to speed up our work.
In the development of new drugs that are said to take 10 years, it is necessary to further speed up, develop and streamline management.
Since its founding in 1950, Fukuzyu Pharmaceutical has been manufacturing APIs and intermediates necessary for the development stage, with a focus on multi-item, small-lot production. We are working to improve our technical capabilities to meet these needs and to speed up our work.
On the other hand, we value the "analog business activities" in which we return to the starting point, look to the customer's face and listen carefully to the request, and build a trusting relationship with the customer day after day.
By clearing inspections by various organizations and companies, including FDA, which is a global indicator, we are striving for safe and secure manufacturing under a further strengthened GMP system.
By clearing inspections by various organizations and companies, including FDA, which is a global indicator, we are striving for safe and secure manufacturing under a further strengthened GMP system.
In recent years, we have been proactively working on contract development, and synthesis which it is difficult to handle, with the slogan of "Think about how to achievement"
By making pharmaceuticals, we are creating a happy future for our customers and local communities.
Based on this belief, we will continue our efforts.
By making pharmaceuticals, we are creating a happy future for our customers and local communities.
Based on this belief, we will continue our efforts.
President Teruo Kosugi
Company Overview
Trade Name | Fukuzyu Pharmaceutical Co., Ltd. |
---|---|
Address | 48, Hagiwara, Toyama, 939-8261, Japan (Site area; 28,000㎡) MAP |
Capital | JPY 60 million |
Founding date | March 27, 1950 |
President | Teruo Kosugi |
Executives |
【President】 Teruo Kosugi 【Senior Managing Director】 Tetsuaki Nishinaga 【Outside Director】 Takayoshi Fujimaki 【Outside Auditor】 Yoko Maeda |
Employee | 80 |
Product lines | Manufacture and sale of ethical drug substances and intermediates / Manufacture of investigational drug substance and intermediates / Research product synthesis contract / Synthetic process development contract / Contracted development of analytical test method / Manufacture of pharmaceutical raw materials Crush of pharmaceutical products / Peptide synthesis contract / flow chemistry contract |
Contact information | 【TEL】 +81-76-429-1151 【FAX】 +81-76-429-6553 |
Customer | Asahi Kasei Pharma Corporation / Astellas Pharma Inc. / DAIICHI SANKYO COMPANY, LIMITED / Eisai Co., Ltd. / FUJIFILM Toyama Chemical Co., Ltd. / KAKEN PHARMACEUTICAL CO., LTD. / KISSEI PHARMACEUTICAL CO., LTD. / Kowa Company, Ltd. / Kyowa Kirin Co., Ltd. / Mitsubishi Tanabe Pharma Corporation / MOCHIDA PHARMACEUTICAL CO., LTD. / Nippon Shinyaku Co., Ltd. / ONO PHARMACEUTICAL CO., LTD. / Sato Pharmaceutical Co., Ltd. / SENJU PHARMACEUTICAL Co., LTD. / Shionogi & Co., Ltd. / Spera Pharma, Inc. / Sumitomo Pharma Co., Ltd. / TAIHO PHARMACEUTICAL CO., LTD. / Taisho Pharmaceutical Co., Ltd. / Takeda Pharmaceutical Company Limited / Toray Industries, Inc. / Several overseas companies |
History
1950 | Started ointment production |
---|---|
1955 | Started chemical synthesis of API |
1959 | Relocation Head office at Toyama to Tokyo |
1964 | Completed Toyama plant |
1977 | Completed Formulation factory in Toyama plant |
1984 | Head Quarters relocated from Tokyo to Toyama |
1985 | Expansion of Formulation factory |
1994 | Completed R&D/QC building |
1996 | The 4th production builiding with a clean room completed (or inaugulated) |
2000 | Completed Raw Material/Product Warehouse and Head office |
2003 | Added a clean room to the 3rd Drying Room |
2004 | The 5th Plant with a clean room added |
2005 | The 2nd Drying Room renovated |
2008 | Added a clean room to the 3nd Drying Room |
2014 | Former formulation factory was renovated as the 6th plant having a containment facility and a clean room |
2018 | Established Technology Development & Research Dept. |
2019 |
Newly established a Process Technology Research Group in Synthetic Chemistry Research Dept. Added Hastelloy reactor to 2nd plant |
2020 | Established Business Planning Division |
2021 |
Business Planning Division integrated into Administration Division Started contracted peptide synthesis |
2022 |
The 1st Plant renovated Established Safety Measures Group. |